1 Tildrakizumab Market Overview 1.1 Product Overview and Scope of Tildrakizumab 1.2 Tildrakizumab Segment by Type 1.2.1 Global Tildrakizumab Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 18MIU /Vial 1.2.3 25MIU /Vial 1.3 Tildrakizumab Segment by Application 1.3.1 Global Tildrakizumab Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Drug Store 1.4 Global Tildrakizumab Market Size Estimates and Forecasts 1.4.1 Global Tildrakizumab Revenue 2016-2027 1.4.2 Global Tildrakizumab Sales 2016-2027 1.4.3 Tildrakizumab Market Size by Region: 2016 Versus 2021 Versus 2027 2 Tildrakizumab Market Competition by Manufacturers 2.1 Global Tildrakizumab Sales Market Share by Manufacturers (2016-2021) 2.2 Global Tildrakizumab Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Tildrakizumab Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Tildrakizumab Manufacturing Sites, Area Served, Product Type 2.5 Tildrakizumab Market Competitive Situation and Trends 2.5.1 Tildrakizumab Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Tildrakizumab Players Market Share by Revenue 2.5.3 Global Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Tildrakizumab Retrospective Market Scenario by Region 3.1 Global Tildrakizumab Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Tildrakizumab Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Tildrakizumab Market Facts & Figures by Country 3.3.1 North America Tildrakizumab Sales by Country 3.3.2 North America Tildrakizumab Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Tildrakizumab Market Facts & Figures by Country 3.4.1 Europe Tildrakizumab Sales by Country 3.4.2 Europe Tildrakizumab Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Tildrakizumab Market Facts & Figures by Region 3.5.1 Asia Pacific Tildrakizumab Sales by Region 3.5.2 Asia Pacific Tildrakizumab Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Tildrakizumab Market Facts & Figures by Country 3.6.1 Latin America Tildrakizumab Sales by Country 3.6.2 Latin America Tildrakizumab Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Tildrakizumab Market Facts & Figures by Country 3.7.1 Middle East and Africa Tildrakizumab Sales by Country 3.7.2 Middle East and Africa Tildrakizumab Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Tildrakizumab Historic Market Analysis by Type 4.1 Global Tildrakizumab Sales Market Share by Type (2016-2021) 4.2 Global Tildrakizumab Revenue Market Share by Type (2016-2021) 4.3 Global Tildrakizumab Price by Type (2016-2021) 5 Global Tildrakizumab Historic Market Analysis by Application 5.1 Global Tildrakizumab Sales Market Share by Application (2016-2021) 5.2 Global Tildrakizumab Revenue Market Share by Application (2016-2021) 5.3 Global Tildrakizumab Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Sun Pharma 6.1.1 Sun Pharma Corporation Information 6.1.2 Sun Pharma Description and Business Overview 6.1.3 Sun Pharma Tildrakizumab Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Sun Pharma Tildrakizumab Product Portfolio 6.1.5 Sun Pharma Recent Developments/Updates 7 Tildrakizumab Manufacturing Cost Analysis 7.1 Tildrakizumab Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Tildrakizumab 7.4 Tildrakizumab Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Tildrakizumab Distributors List 8.3 Tildrakizumab Customers 9 Tildrakizumab Market Dynamics 9.1 Tildrakizumab Industry Trends 9.2 Tildrakizumab Growth Drivers 9.3 Tildrakizumab Market Challenges 9.4 Tildrakizumab Market Restraints 10 Global Market Forecast 10.1 Tildrakizumab Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Tildrakizumab by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Tildrakizumab by Type (2022-2027) 10.2 Tildrakizumab Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Tildrakizumab by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Tildrakizumab by Application (2022-2027) 10.3 Tildrakizumab Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Tildrakizumab by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Tildrakizumab by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Tildrakizumab Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Tildrakizumab Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Tildrakizumab Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Tildrakizumab Covered in This Study Table 5. Global Tildrakizumab Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Tildrakizumab Sales Market Share by Manufacturers (2016-2021) Table 7. Global Tildrakizumab Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Tildrakizumab Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Tildrakizumab Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Tildrakizumab Manufacturing Sites and Area Served Table 11. Manufacturers Tildrakizumab Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Tildrakizumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tildrakizumab as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Tildrakizumab Sales by Region (2016-2021) & (K Units) Table 16. Global Tildrakizumab Sales Market Share by Region (2016-2021) Table 17. Global Tildrakizumab Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Tildrakizumab Sales by Country (2016-2021) & (K Units) Table 19. North America Tildrakizumab Sales Market Share by Country (2016-2021) Table 20. North America Tildrakizumab Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Tildrakizumab Revenue Market Share by Country (2016-2021) Table 22. Europe Tildrakizumab Sales by Country (2016-2021) & (K Units) Table 23. Europe Tildrakizumab Sales Market Share by Country (2016-2021) Table 24. Europe Tildrakizumab Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Tildrakizumab Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Tildrakizumab Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Tildrakizumab Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Tildrakizumab Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Tildrakizumab Revenue Market Share by Region (2016-2021) Table 30. Latin America Tildrakizumab Sales by Country (2016-2021) & (K Units) Table 31. Latin America Tildrakizumab Sales Market Share by Country (2016-2021) Table 32. Latin America Tildrakizumab Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Tildrakizumab Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Tildrakizumab Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Tildrakizumab Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Tildrakizumab Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Tildrakizumab Revenue Market Share by Country (2016-2021) Table 38. Global Tildrakizumab Sales (K Units) by Type (2016-2021) Table 39. Global Tildrakizumab Sales Market Share by Type (2016-2021) Table 40. Global Tildrakizumab Revenue (Million US$) by Type (2016-2021) Table 41. Global Tildrakizumab Revenue Share by Type (2016-2021) Table 42. Global Tildrakizumab Price (USD/Unit) by Type (2016-2021) Table 43. Global Tildrakizumab Sales (K Units) by Application (2016-2021) Table 44. Global Tildrakizumab Sales Market Share by Application (2016-2021) Table 45. Global Tildrakizumab Revenue (Million US$) by Application (2016-2021) Table 46. Global Tildrakizumab Revenue Share by Application (2016-2021) Table 47. Global Tildrakizumab Price (USD/Unit) by Application (2016-2021) Table 48. Sun Pharma Corporation Information Table 49. Sun Pharma Description and Business Overview Table 50. Sun Pharma Tildrakizumab Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Sun Pharma Tildrakizumab Product Table 52. Sun Pharma Recent Developments/Updates Table 53. Production Base and Market Concentration Rate of Raw Material Table 54. Key Suppliers of Raw Materials Table 55. Tildrakizumab Distributors List Table 56. Tildrakizumab Customers List Table 57. Tildrakizumab Market Trends Table 58. Tildrakizumab Growth Drivers Table 59. Tildrakizumab Market Challenges Table 60. Tildrakizumab Market Restraints Table 61. Global Tildrakizumab Sales Forecast by Type (2022-2027) & (K Units) Table 62. Global Tildrakizumab Sales Market Share Forecast by Type (2022-2027) Table 63. Global Tildrakizumab Revenue Forecast by Type (2022-2027) & (US$ Million) Table 64. Global Tildrakizumab Revenue Market Share Forecast by Type (2022-2027) Table 65. Global Tildrakizumab Sales Forecast by Application (2022-2027) & (K Units) Table 66. Global Tildrakizumab Sales Market Share Forecast by Application (2022-2027) Table 67. Global Tildrakizumab Revenue Forecast by Application (2022-2027) & (US$ Million) Table 68. Global Tildrakizumab Revenue Market Share Forecast by Application (2022-2027) Table 69. Global Tildrakizumab Sales Forecast by Region (2022-2027) & (K Units) Table 70. Global Tildrakizumab Sales Market Share Forecast by Region (2022-2027) Table 71. Global Tildrakizumab Revenue Forecast by Region (2022-2027) & (US$ Million) Table 72. Global Tildrakizumab Revenue Market Share Forecast by Region (2022-2027) Table 73. Research Programs/Design for This Report Table 74. Key Data Information from Secondary Sources Table 75. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Tildrakizumab Figure 2. Global Tildrakizumab Market Share by Type in 2020 & 2027 Figure 3. 18MIU /Vial Product Picture Figure 4. 25MIU /Vial Product Picture Figure 5. Global Tildrakizumab Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Drug Store Figure 8. Global Tildrakizumab Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Tildrakizumab Market Size 2016-2027 (US$ Million) Figure 10. Global Tildrakizumab Sales 2016-2027 (K Units) Figure 11. Global Tildrakizumab Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Tildrakizumab Sales Share by Manufacturers in 2020 Figure 13. Global Tildrakizumab Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Tildrakizumab Players: Market Share by Revenue in 2020 Figure 15. Tildrakizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Tildrakizumab Sales Market Share by Region (2016-2021) Figure 17. Global Tildrakizumab Sales Market Share by Region in 2020 Figure 18. Global Tildrakizumab Revenue Market Share by Region (2016-2021) Figure 19. Global Tildrakizumab Revenue Market Share by Region in 2020 Figure 20. U.S. Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. UAE Tildrakizumab Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Tildrakizumab by Type (2016-2021) Figure 45. Sales Market Share of Tildrakizumab by Application (2016-2021) Figure 46. Sales Market Share of Tildrakizumab by Application in 2020 Figure 47. Revenue Share of Tildrakizumab by Application (2016-2021) Figure 48. Revenue Share of Tildrakizumab by Application in 2020 Figure 49. Manufacturing Cost Structure of Tildrakizumab Figure 50. Manufacturing Process Analysis of Tildrakizumab Figure 51. Tildrakizumab Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Sun Pharma